
Aflac Incorporated
- Jurisdiction
United States - LEI
549300N0B7DOGLXWPP39 - ISIN
US0010551028 (AFL )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
3
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
3
/ 7
Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. Read full profile
Fundamentals
- Net revenue
€13.77B - Gross margin
59.9% - EBIT
€2.72B - EBIT margin
19.8% - Net income
€2.08B - Net margin
15.1%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Stock price
Dividends
- Last dividend amount
-
$0.58 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
46.9%
Analyst ratings
No analyst ratings available
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
MOSKOWITZ JOSEPH L | N/A |
|
|
|
|
Congress transactions
Name | Transaction date | Value |
---|---|---|
Shelley Capito | July 18, 2025 | $1.00K–$15.00K |
Carol Miller | April 11, 2025 | $1.00K–$15.00K |
Shelley Capito | January 17, 2025 | $1.00K–$15.00K |
Earnings Calls
Investor transactions
Name | Shares | Value | Last change | Change type |
---|---|---|---|---|
Peter Brown |
|
|
|
Sell |
Earnings Calls
Latest earnings call: May 2, 2024 (Q1 2024)